Brain Involvement in Myotonic Dystrophy Type I: From Functional Neuroimaging to the Impact on Quality of Life

NCT03589677 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-07-18

No results posted yet for this study

Summary

This project aims to characterize DM1 patients, by collecting clinical, neuropsychological, neuroimaging, and molecular rehabilitative data, in order to elucidate the etiology of cognitive troubles, with special attention to the impact of those dysfunctions on quality of life.

Conditions

  • Myotonic Dystrophy Type 1 (DM1)

Sponsors & Collaborators

  • IRCCS San Camillo, Venezia, Italy

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-03
Primary Completion
2015-06-04
Completion
2015-06-04

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03589677 on ClinicalTrials.gov